Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes.
Rodney, Alan M.D. 1; Dieringer, Pauline R.N. 1; Mathew, Paul M.D. 1; Jonasch, Eric M.D. 1; Tannir, Nizar M.D. 1; Pagliaro, Lance C. M.D. 1,*,+
106(10):2143-2147, May 15, 2006.
(Format: HTML, PDF)